Skip to content

Clinical trials

Phase 2 trials in Jordan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2 Country / region: Jordan Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20092
20101
20121
20143
20163
20172
20185
20194
20201
20211
20226
20242
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Active, not recruiting6
Recruiting6
Unknown status5
Enrolling by invitation2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals8
European Organisation for Research and Treatment of Cancer - EORTC3
Janssen Research & Development, LLC2
Spyre Therapeutics, Inc.2
University of Jordan2
Al-Balqa Applied University1
Ali Shamseddine1
Arafat Tfayli1
Bristol-Myers Squibb1
Hayat Pharmaceutical Co. PLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms4
Colitis, Ulcerative4
Inflammatory Bowel Diseases3
Carcinoma, Non-Small-Cell Lung2
Colitis2
Vitamin D Deficiency2
Anemia, Sickle Cell1
Asthma1
COVID-191
Central Nervous System Neoplasms1

Trials

Showing 51 to 40 of 40. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.